ASO Author Reflections: Clinical Implications of Programmed Death-Ligand 2 (PD-L2) Expression as an Independent Prognostic Marker in Lung Adenocarcinoma: Different Characteristics of PD-L2-Positive Patients from Those with Programmed Death-Ligand 1.

Saved in:
Bibliographic Details
Title: ASO Author Reflections: Clinical Implications of Programmed Death-Ligand 2 (PD-L2) Expression as an Independent Prognostic Marker in Lung Adenocarcinoma: Different Characteristics of PD-L2-Positive Patients from Those with Programmed Death-Ligand 1.
Authors: Takamori S; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. takamori@med.kyushu-u.ac.jp., Takada K; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan., Maehara Y; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Source: Annals of surgical oncology [Ann Surg Oncol] 2019 Dec; Vol. 26 (Suppl 3), pp. 668-669. Date of Electronic Publication: 2019 Jul 31.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-4681
DOI:10.1245/s10434-019-07680-6